» Articles » PMID: 21837239

Potential Explanatory Factors for Higher Incident Hip Fracture Risk in Older Diabetic Adults

Overview
Specialty Geriatrics
Date 2011 Aug 13
PMID 21837239
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes is associated with higher fracture risk. Diabetes-related conditions may account for this risk. Cardiovascular Health Study participants (N = 5641; 42.0% men; 15.5% black; 72.8±5.6 years) were followed 10.9 ± 4.6 years. Diabetes was defined as hypoglycemic medication use or fasting glucose (FG) ≥126 mg/dL. Peripheral artery disease (PAD) was defined as ankle-arm index <0.9. Incident hip fractures were from medical records. Crude hip fracture rates (/1000 person-years) were higher for diabetic vs. non-diabetic participants with BMI <25 (13.6, 95% CI: 8.9-20.2 versus 11.4, 95% CI: 10.1-12.9) and BMI ≥25 to <30 (8.3, 95% CI: 5.7-11.9 versus 6.6, 95% CI: 5.6-7.7), but similar for BMI ≥30. Adjusting for BMI, sex, race, and age, diabetes was related to fractures (HR = 1.34; 95% CI: 1.01-1.78). PAD (HR = 1.25 (95% CI: 0.92-1.57)) and longer walk time (HR = 1.07 (95% CI: 1.04-1.10)) modified the fracture risk in diabetes (HR = 1.17 (95% CI: 0.87-1.57)). Diabetes was associated with higher hip fracture risk after adjusting for BMI though this association was modified by diabetes-related conditions.

Citing Articles

Differences in the roles of types 1 and 2 diabetes in the susceptibility to the risk of fracture: a systematic review and meta-analysis.

Dou J, Wang J, Zhang Q Diabetol Metab Syndr. 2021; 13(1):84.

PMID: 34399851 PMC: 8369647. DOI: 10.1186/s13098-021-00687-8.


Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis.

Wang H, Ba Y, Xing Q, Du J BMJ Open. 2019; 9(1):e024067.

PMID: 30610024 PMC: 6326306. DOI: 10.1136/bmjopen-2018-024067.


The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.

Yang J, Huang C, Wu S, Xu Y, Cai T, Chai S PLoS One. 2017; 12(12):e0187537.

PMID: 29206832 PMC: 5716604. DOI: 10.1371/journal.pone.0187537.


Diabetes, bone and glucose-lowering agents: clinical outcomes.

Schwartz A Diabetologia. 2017; 60(7):1170-1179.

PMID: 28451714 DOI: 10.1007/s00125-017-4283-6.


Diabetes mellitus and risk of hip fractures: a meta-analysis.

Fan Y, Wei F, Lang Y, Liu Y Osteoporos Int. 2015; 27(1):219-28.

PMID: 26264604 DOI: 10.1007/s00198-015-3279-7.


References
1.
Janghorbani M, van Dam R, Willett W, Hu F . Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007; 166(5):495-505. DOI: 10.1093/aje/kwm106. View

2.
Ivers R, Cumming R, Mitchell P, Peduto A . Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care. 2001; 24(7):1198-203. DOI: 10.2337/diacare.24.7.1198. View

3.
Ottenbacher K, Ostir G, Peek M, Goodwin J, Markides K . Diabetes mellitus as a risk factor for hip fracture in mexican american older adults. J Gerontol A Biol Sci Med Sci. 2002; 57(10):M648-53. DOI: 10.1093/gerona/57.10.m648. View

4.
Nicodemus K, Folsom A . Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care. 2001; 24(7):1192-7. DOI: 10.2337/diacare.24.7.1192. View

5.
Fried L, Biggs M, Shlipak M, Seliger S, Kestenbaum B, Stehman-Breen C . Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol. 2006; 18(1):282-6. DOI: 10.1681/ASN.2006050546. View